20 results

• Tysabri PML Risk-Minimization Strategies Working, Study Finds

  September 16, 2019

  Martha Garcia

  Tysabri PML rates are on the decline after preventative guidelines went into effect, according to a new study.

• Tecfidera Side Effects Could Cause Liver Injury, New Label Warnings Added

  January 27, 2017

  Irvin Jackson

  New label warnings indicate that the side effects of Tecfidera could cause liver injuries requiring hospitalization.

• Tecfidera Brain Infection Results in FDA Warning Label Update

  November 26, 2014

  Irvin Jackson

  The FDA is requiring a new label warning detailing the death of a patient due to brain infection for the MS drug Tecfidera.

• PML Brain Infection Diagnosed in Gilenya User

  April 16, 2012

  Staff Writers

  A patient taking the multiple sclerosis drug Gilenya has been diagnosed with a rare and often fatal brain infection.

• Raptiva Recall Lawsuit Trial Over Fatal Infection Delayed

  January 26, 2012

  Staff Writers

  The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back...

• Tysabri Brain Infection Risk Updated on Drug Label

  April 12, 2011

  Staff Writers

  The label information on the multiple sclerosis drug Tysabri is being updated to reflect new data on the risk of...

• Raptiva Infection Lawsuit Filed Over Meningitis and Acute Retinal Necrosis

  February 3, 2011

  Staff Writers

  A Raptiva infection lawsuit has been filed by a Massachusetts man who claims that the recalled psoriasis drug caused him...

• Raptiva Lawsuit Filed By User Who Developed Lymphoma

  January 11, 2011

  Staff Writers

  A Texas man who was diagnosed with classic Hodgkin’s lymphoma has filed a Raptiva lawsuit, alleging that the recalled psoriasis...

• Tysabri Linked to Serious Brain Infection PML in 79 People, 16 Deaths

  December 20, 2010

  Staff Writers

  According to new data released by Biogen Idec, their once-recalled multiple sclerosis drug Tysabri has been linked to at least...

• FDA Warns Drug Maker For Minimizing Risk of Brain Infection from Tysabri

  April 8, 2010

  Staff Writers

  Federal regulators have cited Biogen Idec, Inc. for attempting to downplay the risks of a rare, but often fatal, brain...